RVPH
Price
$0.45
Change
+$0.04 (+9.76%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
27.68M
7 days until earnings call
TCRT
Price
$2.58
Change
+$0.12 (+4.86%)
Updated
Aug 11, 04:57 PM (EDT)
Capitalization
4.05M
Interact to see
Advertisement

RVPH vs TCRT

Header iconRVPH vs TCRT Comparison
Open Charts RVPH vs TCRTBanner chart's image
Reviva Pharmaceuticals Holdings
Price$0.45
Change+$0.04 (+9.76%)
Volume$3.24K
Capitalization27.68M
Alaunos Therapeutics
Price$2.58
Change+$0.12 (+4.86%)
Volume$100
Capitalization4.05M
RVPH vs TCRT Comparison Chart in %
Loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVPH vs. TCRT commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVPH is a StrongBuy and TCRT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (RVPH: $0.41 vs. TCRT: $2.47)
Brand notoriety: RVPH and TCRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVPH: 77% vs. TCRT: 165%
Market capitalization -- RVPH: $27.68M vs. TCRT: $4.05M
RVPH [@Biotechnology] is valued at $27.68M. TCRT’s [@Biotechnology] market capitalization is $4.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVPH’s FA Score shows that 1 FA rating(s) are green whileTCRT’s FA Score has 0 green FA rating(s).

  • RVPH’s FA Score: 1 green, 4 red.
  • TCRT’s FA Score: 0 green, 5 red.
According to our system of comparison, RVPH is a better buy in the long-term than TCRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVPH’s TA Score shows that 5 TA indicator(s) are bullish while TCRT’s TA Score has 4 bullish TA indicator(s).

  • RVPH’s TA Score: 5 bullish, 3 bearish.
  • TCRT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RVPH is a better buy in the short-term than TCRT.

Price Growth

RVPH (@Biotechnology) experienced а -6.54% price change this week, while TCRT (@Biotechnology) price change was -9.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

RVPH is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVPH($27.7M) has a higher market cap than TCRT($4.05M). TCRT YTD gains are higher at: 29.659 vs. RVPH (-77.508). TCRT has higher annual earnings (EBITDA): -4.03M vs. RVPH (-28.87M). RVPH has more cash in the bank: 5.29M vs. TCRT (319K). TCRT has less debt than RVPH: TCRT (0) vs RVPH (224K). TCRT has higher revenues than RVPH: TCRT (11K) vs RVPH (0).
RVPHTCRTRVPH / TCRT
Capitalization27.7M4.05M684%
EBITDA-28.87M-4.03M717%
Gain YTD-77.50829.659-261%
P/E RatioN/AN/A-
Revenue011K-
Total Cash5.29M319K1,658%
Total Debt224K0-
FUNDAMENTALS RATINGS
RVPH vs TCRT: Fundamental Ratings
RVPH
TCRT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCRT's Valuation (69) in the Biotechnology industry is in the same range as RVPH (92) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

TCRT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

TCRT's SMR Rating (99) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

TCRT's Price Growth Rating (65) in the Biotechnology industry is in the same range as RVPH (65) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

RVPH's P/E Growth Rating (11) in the null industry is significantly better than the same rating for TCRT (100) in the Biotechnology industry. This means that RVPH’s stock grew significantly faster than TCRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVPHTCRT
RSI
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD23.920.80
+3.48%
Tvardi Therapeutics Inc
PNC189.742.62
+1.40%
PNC Financial Services Group
MRUS64.000.61
+0.96%
Merus NV
THRM32.74-0.36
-1.09%
Gentherm
NINE0.63-0.04
-6.21%
Nine Energy Service

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-5.04%
ALT - RVPH
50%
Loosely correlated
-1.99%
GYRE - RVPH
31%
Poorly correlated
-0.14%
INDP - RVPH
30%
Poorly correlated
+6.34%
INM - RVPH
27%
Poorly correlated
N/A
TSHA - RVPH
24%
Poorly correlated
-3.20%
More

TCRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with GLTO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
-5.00%
GLTO - TCRT
56%
Loosely correlated
+3.68%
DSGN - TCRT
56%
Loosely correlated
+7.81%
BTAI - TCRT
26%
Poorly correlated
+18.48%
RVPH - TCRT
25%
Poorly correlated
-5.04%
NURPF - TCRT
24%
Poorly correlated
N/A
More